Susan Hasty, Publisher
Table of Contents . . . May 2nd, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Antimicrobial Agents - Orthophthalaldehyde surpasses glutaraldehyde for disinfecting medical devices
Chronic Liver Disease - Liver steatosis predicts how hepatitis C patients will respond to interferon
Hepatitis B Therapy - Long-term lamivudine improves outcomes for chronic hepatitis B patients
Hepatitis B Vaccine - Immune response to hepatitis B DNA vaccine improves upon protein boosting
Hepatitis C Virus - Hepatitis C virus constructs model viral behavior in vitro
Addiction Medicine - Hepatitis C-positive injection drug users remain RNA negative after therapy
Adverse Drug Reaction - Hepatitis C therapies sometimes produce pulmonary toxicity
Avian Influenza - Germicidal product passes efficacy test for eradicating bird flu virus
Bacille Calmette-Guerin Infection - PB/BM findings described in disseminated bacille Calmette-Guerin infection
Cancer Risk Factors - HBV genotype A raises liver cancer risk in Bantu-speaking sub-Saharan Africans
Cancer Therapy - Liver-selective thyromimetic KAT-681 prevents liver tumors in rodent models
Diagnostics - Studies describe new findings in diagnostics research
Chronic Hepatitis C - Immunoregulatory cytokine polymorphisms do not predict hepatitis C clearance
Complementary & Alternative Medicine - Korean herbal medicine Panax notoginseng prevents rodent liver dysfunction
Diagnostics - Reports describe recent advances in diagnostics research
Drug Development - CEL-1000 peptide effective against viral encephalitis in mice
Drug Development - Replicon systems are not exact predictors of anti-hepatitis C activity
Virology - Recent findings illuminate research in virology
Drug Resistance - Findings in drug resistance provide new insights
Enzymology - HBV X protein-induced enzyme activity causes cancer
Fatty Liver Disease - Serum antioxidant levels change in patients with non-alcoholic steatohepatitis
Finance - Biopharmaceutical company updates its 2005 revenue guidance
Gene Transfer - Optimized ligand conjugation degree improves PPA gene carrier ability
HIV/AIDS Therapy - Chronic viral hepatitis alters the pharmacokinetics of antiretroviral therapy
Virology - Researchers publish new studies and findings in the area of virology
Hematology - New findings in hematology described
Hepatitis A Virus - Hepatitis A virus grown in mouse liver cell line
Hepatitis B Virus - Biotech company granted CE mark for two diagnostic tests
Hepatitis C Therapy - Pharmacological inhibition of viral protease restores antiviral function
Hepatitis E Virus - Interactions involved in assembly of hepatitis E virus capsid analyzed
Hepatitis Treatment - What researchers learn about NK cells could yield hepatitis treatment
Virology - Researchers report details of new studies and findings in the area of virology
Liver Cancer - Molecular signatures characterize hepatocellular carcinoma
Medical Devices - Reference site established to use patch clamp system for cardio drug discovery
Natural Products - Tridax procumbens extract defends rat livers against oxidative stress
Systemic Lupus Erythematosus - Company announces preliminary results of Genovate's clinical trial of prasterone
Thrombosis - Autoimmune hepatitis accompanies antiphospholipid syndrome
Transplant Medicine - Studies add new findings to transplant medicine body of knowledge
Virology - Researchers' work adds to virology body of knowledge
Vaccine Development - Hepatitis B virus capsid protein is a potent antigen carrier for vaccines
Virology - Findings in virology provide new insights
Virology - Hepatitis C virus NS5B mutations affect viral load and interferon response
Virology - Hepatitis C virus isolates exhibit NS3 protease heterogeneity
Virology - Viruses rely on different factors for capsid protein assembly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.